(S (NP (NP (NP (VBN Automated) (ADJP (NN computer) (HYPH -) (VBN aided)) (NN detection)) (-LRB- -LRB-) (NP (NN CADe)) (-RRB- -RRB-)) (PP (IN in) (NP (JJ medical) (NN imaging)))) (VP (VBZ has) (VP (VBN been) (NP (NP (DT an) (JJ important) (NN tool)) (PP (IN in) (NP (JJ clinical) (NN practice) (CC and) (NN research)))))) (. .))
(S (NP (NML (NML (NN State)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (NNS methods)) (ADVP (RB often)) (VP (VBP show) (NP (JJ high) (NNS sensitivities)) (PP (CC but) (IN at) (NP (NP (DT the) (NN cost)) (PP (IN of) (NP (NP (NP (JJ high) (JJ false) (HYPH -) (NNS positives)) (-LRB- -LRB-) (NP (NN FP)) (-RRB- -RRB-)) (PP (IN per) (NP (NN patient) (NNS rates)))))))) (. .))
(S (PP (IN By) (S (VP (VBG leveraging) (S (VP (VBG existing) (NP (NNP CAD) (NNS systems))))))) (, ,) (NP (NP (NNS coordinates)) (PP (IN of) (NP (NP (NNS regions) (CC or) (NNS volumes)) (PP (IN of) (NP (NP (NN interest) (PRN (-LRB- -LRB-) (NP (NN ROI) (CC or) (NN VOI)) (-RRB- -RRB-))) (PP (IN for) (NP (NN lesion) (NNS candidates)))))))) (VP (VBP are) (VP (VBN generated) (PP (IN in) (NP (NP (DT this) (NN step) (CC and) (NN function)) (PP (IN as) (NP (NN input))))) (PP (IN for) (NP (NP (DT a) (JJ second) (NN tier)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (PRP$ our) (NN focus)) (PP (IN in) (NP (DT this) (NN study))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (JJ second) (NN stage))) (, ,) (NP (PRP we)) (VP (VBP generate) (NP (NP (QP ($ $) (CD N$) (CD 2D)) (PRN (-LRB- -LRB-) (ADJP (CD two) (HYPH -) (JJ dimensional)) (-RRB- -RRB-))) (CC or) (NP (NP (CD 2.5) (ADJP (JJ D)) (NNS views)) (PP (IN via) (NP (NN sampling))))) (PP (IN through) (NP (NP (NN scale) (NNS transformations)) (, ,) (NP (NP (JJ random) (NNS translations) (CC and) (NNS rotations)) (PP (IN with) (NP (NN respect)))))) (PP (IN to) (NP (NP (DT each) (NN ROI) (POS 's)) (JJ centroid) (NNS coordinates)))) (. .))
(S (NP (DT These) (JJ random) (NNS views)) (VP (VBP are) (VP (VBN used) (S (VP (TO to) (VP (VB train) (NP (JJ deep) (JJ convolutional) (NML (NML (JJ neural) (NN network)) (-LRB- -LRB-) (NML (NP (NNP ConvNet))) (-RRB- -RRB-)) (NNS classifiers))))))) (. .))
(SINV (PP (IN In) (NP (NP (NN testing)) (, ,) (NP (DT the) (VBN trained) (NNPS ConvNets)))) (VP (VBP are) (VP (VBN employed) (S (VP (TO to) (VP (VB assign) (NP (NML (NN class) (PRN (-LRB- -LRB-) (ADVP (FW e.g.)) (, ,) (NP (NN lesion) (, ,) (NN pathology)) (-RRB- -RRB-))) (NNS probabilities)) (PP (IN for) (NP (NP (DT a) (JJ new) (NN set)) (PP (IN of) (NP ($ $) (CD N$)))))))))) (NP (NP (JJ random) (NNS views)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB then)) (VP (VBN averaged) (PP (IN at) (NP (DT each) (NN ROI))) (PP (IN to) (VP (VB compute) (NP (DT a) (JJ final) (NML (NML (IN per) (HYPH -) (NN candidate)) (NN classification)) (NN probability))))))))) (. .))
(S (NP (DT This) (JJ second) (NN tier)) (VP (VBZ behaves) (PP (IN as) (NP (DT a) (ADJP (RB highly) (JJ selective)) (NN process))) (S (VP (TO to) (VP (VB reject) (NP (JJ difficult) (JJ false) (NNS positives)) (PP (IN while) (S (VP (VBG preserving) (NP (JJ high) (NNS sensitivities))))))))) (. .))
(S (NP (DT The) (NNS methods)) (VP (VBP are) (VP (VBN evaluated) (PP (IN on) (NP (CD three) (JJ different) (NNS data) (NNS sets))) (PP (IN with) (NP (NP (NP (NP (JJ different) (NNS numbers)) (PP (IN of) (NP (NNS patients)))) (: :) (NP (NP (CD 59) (NNS patients)) (PP (IN for) (NP (JJ sclerotic) (NNS metastases) (NN detection))))) (, ,) (NP (NP (CD 176) (NNS patients)) (PP (IN for) (NP (NN lymph) (NN node) (NN detection)))) (, ,) (CC and) (NP (NP (CD 1,186) (NNS patients)) (PP (IN for) (NP (JJ colonic) (NN polyp) (NN detection)))))))) (. .))
(S (NP (JJ Experimental) (NNS results)) (VP (VBP show) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NNPS ConvNets)))) (S (VP (TO to) (VP (VB generalize) (ADVP (RB well) (PP (IN to) (NP (JJ different) (NML (JJ medical) (NN imaging) (NN CADe)) (NNS applications) (CC and) (NN scale)) (ADVP (RB elegantly)))) (PP (IN to) (NP (JJ various) (NNS data) (NNS sets))))))) (. .))
(S (NP (PRP$ Our) (VBN proposed) (NNS methods)) (VP (VBP improve) (NP (NN CADe) (NN performance)) (ADVP (RB markedly)) (PP (IN in) (NP (DT all) (NNS cases)))) (. .))
(S (NP (NN CADe) (NNS sensitivities)) (VP (VP (VBN improved) (PP (IN from) (NP (QP (CD 57) (NN %) (IN to) (CD 70) (NN %)))) (, ,) (PP (IN from) (NP (QP (CD 43) (NN %) (IN to) (CD 77) (NN %))))) (CC and) (VP (PP (IN from) (NP (QP (CD 58) (NN %) (IN to) (CD 75) (NN %)))) (PP (IN at) (NP (NP (CD 3) (NNS FPs)) (PP (IN per) (NP (NN patient))))) (PP (IN for) (NP (NP (JJ sclerotic) (NNS metastases)) (, ,) (NP (NN lymph) (NNS nodes)) (CC and) (NP (JJ colonic) (NNS polyps))) (, ,) (ADVP (RB respectively))))) (. .))
